|
doxorubicin hydrochloride 2 mg/mL INJECTION, SOLUTION
Sagent · NDC 25021-0207-25 · J9000 · 1 VIAL in 1 CARTON (25021-207-25) / 25 mL in 1 VIAL |
25021-0207-25 |
— |
On market |
View → |
|
Doxorubicin Hydrochloride 2 mg/mL INJECTION, SOLUTION
Hikma · NDC 00143-9088-01 · J9000 · 1 VIAL in 1 BOX (0143-9088-01) / 5 mL in 1 VIAL |
00143-9088-01 |
— |
On market |
View → |
|
Doxorubicin Hydrochloride 2 mg/mL INJECTION, SOLUTION
Hikma · NDC 00143-9089-01 · J9000 · 1 VIAL in 1 BOX (0143-9089-01) / 10 mL in 1 VIAL |
00143-9089-01 |
— |
On market |
View → |
|
Doxorubicin Hydrochloride 2 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Hikma · NDC 00143-9093-01 · J9000 · 1 VIAL in 1 BOX (0143-9093-01) / 25 mL in 1 VIAL |
00143-9093-01 |
— |
On market |
View → |
|
DOXORUBICIN HYDROCHLORIDE 2 mg/mL INJECTABLE, LIPOSOMAL
Zydus · NDC 70710-1530-01 · Q2050 · 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1530-1) / 10 mL in 1 VIAL, SINGLE-DOSE |
70710-1530-01 |
— |
On market |
View → |
|
DOXORUBICIN HYDROCHLORIDE 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
Lupin · NDC 70748-0339-01 · Q2050 · 1 VIAL, SINGLE-USE in 1 CARTON (70748-339-01) / 10 mL in 1 VIAL, SINGLE-USE |
70748-0339-01 |
— |
On market |
View → |
|
doxorubicin hydrochloride 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
BluePoint · NDC 68001-0706-36 · 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-706-36) / 10 mL in 1 VIAL, SINGLE-DOSE |
68001-0706-36 |
— |
On market |
View → |
|
doxorubicin hydrochloride 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
BluePoint · NDC 68001-0707-26 · 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-707-26) / 25 mL in 1 VIAL, SINGLE-DOSE |
68001-0707-26 |
— |
On market |
View → |
|
doxorubicin hydrochloride 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
Alembic · NDC 62332-0810-10 · 1 VIAL, SINGLE-DOSE in 1 CARTON (62332-810-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
62332-0810-10 |
— |
On market |
View → |
|
doxorubicin hydrochloride 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
Alembic · NDC 62332-0525-25 · 1 VIAL, SINGLE-DOSE in 1 CARTON (62332-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE |
62332-0525-25 |
— |
On market |
View → |
|
Doxorubicin Hydrochloride Liposome 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
Sagent · NDC 25021-0263-10 · Q2050 · 1 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL |
25021-0263-10 |
— |
On market |
View → |
|
doxorubicin hydrochloride, Liposomal 2 mg/mL INJECTION, SUSPENSION, LIPOSOMAL
Baxter · NDC 00338-9581-02 · 1 VIAL, SINGLE-USE in 1 CARTON (0338-9581-02) / 10 mL in 1 VIAL, SINGLE-USE (0338-9581-01) |
00338-9581-02 |
— |
On market |
View → |